Publication | Closed Access

Safety and tolerability of recombinant modified vaccinia virus Ankara expressing an HIV-1 gag/multiepitope immunogen (MVA.HIVA) in HIV-1-infected persons receiving combination antiretroviral therapy

VaccinationVaccine DevelopmentCombination Antiretroviral TherapyVaccine TargetImmunologyAntiviral TherapyVirologyVaccinia Virus AnkaraHiv-1 Gag/multiepitope ImmunogenAntiviral DrugHivMedicine